Home › Neurologic Diseases › Texas
Neurologic Diseases clinical trials in Texas
14 studies for Neurologic Diseases are looking for participants at sites in Texas.
Cities in Texas
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- Gadolin Research, Beaumont
- Kerwin Medical Center, Dallas
- Houston Methodist Hospital, Houston
- and 3 more
RecruitingPhase 2
Ages 55 to 85 · All sexes · Updated Sep 22, 2026 · NCT07589595Product Surveillance Registry
- Austin
- Dallas
- Fort Worth
- and 6 more
RecruitingObservational study
All ages · All sexes · Updated Sep 18, 2026 · NCT01524276A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
- Austin, Texas, Austin
- Dallas, Texas, Dallas
- San Antonio, Texas, San Antonio
- and 1 more
RecruitingPhase 2/3
Ages 18 to 70 · All sexes · Updated Sep 11, 2026 · NCT07598708A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
- Vima Site #049, Cypress
- Vima Site #063, Dallas
- Vima Site #058, Round Rock
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Sep 11, 2026 · NCT07804615Multiple Dose Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases
- The Cancer Therapy and Research Center at UTHSCSA, San Antonio
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT07098806HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
- MD Anderson Cancer Center, Houston
RecruitingPhase 1
36 Months – 22 Years · All sexes · Updated Sep 4, 2026 · NCT03911388A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Clinical Site, Austin
- Clinical Site, DeSoto
- Clinical Site, Richardson
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Sep 1, 2026 · NCT07459647A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, Austin
- Clinical Site, McKinney
- Clinical Site, Sugarland
RecruitingPhase 2
Ages 55 to 90 · All sexes · Updated Aug 27, 2026 · NCT06887192Music-4-MS to Improve Cognition in People Living With Multiple Sclerosis: A Feasibility Study
- University of Texas at Austin, Austin
Recruiting
Ages 18 to 80 · All sexes · Updated Aug 17, 2026 · NCT07759115Rett Syndrome Registry
- Children's Health, Dallas
- Texas Children's Hospital, Houston
RecruitingObservational study
Ages 0 to 99 · All sexes · Updated Jun 30, 2026 · NCT05432349INdependence Through Endovascular Neuroprosthetic Technology (INTENT): an Early Feasibility Study
- University of Texas Southwestern Medical Center (UTSW), Dallas
Recruiting
Ages 22 and older · All sexes · Updated May 11, 2026 · NCT07543367Open-label Extension Study in Participants With Early Alzheimer's Disease
- GSK Investigational Site, Houston
RecruitingPhase 2
Ages 50 to 85 · All sexes · Updated Feb 2, 2026 · NCT07105709Reliability and Validity of the PReFS
- Baylor University, Waco
RecruitingObservational study
Ages 18 and older · All sexes · Updated Dec 23, 2025 · NCT07280923Epilepsy Learning Healthcare System (ELHS)
- UT Southwestern Children's Dallas, Dallas
RecruitingObservational study
All ages · All sexes · Updated Aug 30, 2024 · NCT06265103From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.